A trial looking at higher dose radiotherapy for non small cell lung cancer (I-START)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

Lung cancer
Non small cell lung cancer




Phase 1/2

This trial is looking at giving a higher than normal dose of radiotherapy for non small cell lung cancer. This trial is supported by Cancer Research UK.

If you have non small cell lung cancer and cannot have surgery, your doctor may suggest that you have radiotherapy to try to get rid of the cancer cells.  

Researchers think that giving a higher dose of radiotherapy may kill off more cancer cells. But they want to do this without damaging the surrounding healthy tissue such as your food pipe.

In this trial, they will increase the amount of radiotherapy and see how well it works on the cancer cells. They will also check what effect more radiotherapy has on the nearby healthy cells.  

The aims of this trial are to find out

  • If increasing the amount of radiotherapy you have each day is better at killing the cancer cells
  • What the maximum safe dose of radiotherapy is to your food pipe (oesophagus)
  • How well this maximum dose works
  • Whether the higher dose causes more or worse side effects

Who can enter

You may be able to enter this trial if you

  • Have non small cell lung cancer that is stage 2, 3A or 3B
  • Have been told your cancer cannot be treated with surgery or you have chosen not to have surgery
  • Are well enough to be up and about for at least half the day (performance status 0, 1 or 2)
  • Have satisfactory lung function tests Open a glossary item
  • Have satisfactory blood test results
  • Are willing to use reliable contraception if you or your partner could become pregnant
  • Are at least 16 years old

You cannot enter this trial if 

  • You have already had radiotherapy to your chest
  • You have a type of lung cancer called a Pancoast tumour
  • One of your lungs or a section (lobe) of one of your lungs isn't working properly
  • You have a connective tissue Open a glossary item disorder such as scleroderma or systemic lupus erythematosus Open a glossary item
  • You have had another cancer that could affect you taking part in this trial
  • You have another medical condition that is not controlled with medication
  • You are pregnant or breastfeeding

Trial design

There are 2 parts to this phase 1/2 trial. In the first part, the researchers want to find the highest dose of radiotherapy they can give.

Everybody taking part will have radiotherapy. The first few people will have a dose that is a little bit higher than what you would receive for your normal treatment.  If they don’t have any serious side effects, the next few people will have a slightly higher dose again. As long as there are no serious side effects this will be repeated twice more with higher doses. In this way the researchers find the highest dose they can give safely.  This is called a ‘dose escalation’ study.  

In the second part of the trial, the researchers will give the highest dose possible based on what they know from part 1. The researchers will give a higher dose than standard as long as the dose to other parts of your body is still safe. This part will also find out how well the highest dose of radiotherapy works. It will also see if a higher dose makes the side effects worse.

You have radiotherapy once a day from Monday to Friday for 4 weeks.

Hospital visits

You see the doctor and have some tests before taking part in this trial.  These tests include

  • Chest X-ray
  • CT scan
  • PET scan
  • Lung function test Open a glossary item
  • Blood test
  • A physical examination
  • Heart trace  (ECG Open a glossary item)
  • Bone scan – if needed

During treatment you see the doctor every week for a physical examination and blood test.

When you finish treatment you go back and see the doctor about 1 month later for a physical examination and blood test.

After that you see the doctor every month for 3 months and then every 3 months for 2 years. At each visit you have a physical examination and chest X-ray. After 12 weeks you have a lung function test and a CT scan.  After a year you have another lung function test.  The researchers will also ask you how you have been and if you have any side effects.

Side effects

The side effects of radiotherapy for lung cancer can include

We have more information about the general side effects of lung cancer radiotherapy in our lung cancer section.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Jason Lester

Supported by

Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Velindre NHS Trust
Wales Cancer Trials Unit

Other information

This is Cancer Research UK trial number CRUK/10/005.

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 5092

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think